Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: A collaborative study in Europe

Prenatal Diagnosis

Volumn 34, Issue 2, 2014, Pages 185-191

  Stumm, Markus ^a   Entezami, Michael ^a   Haug, Karsten ^b   Blank, Cornelia ^b   Wüstemann, Max ^c   Schulze, Bernt ^d   Raabe Meyer, Gisela ^d   Hempel, Maja ^e   Schelling, Markus ^f   Ostermayer, Eva ^e   Langer Freitag, Sabine ^e   Burkhardt, Tilo ^g   Zimmermann, Roland ^g   Schleicher, Tina ^h   Weil, Bernd ⁱ   Schöck, Ulrike ⁱ   Smerdka, Patricia ⁱ   Grömminger, Sebastian ⁱ   Kumar, Yadhu ^h   Hofmann, Wera ⁱ  

^a Zentrum fur Pranataldiagnostik und Humangenetik   (Germany)

^b Institut für Pränatal Medizin und Genetik   (Germany)

^c Zentrum für Pränatalmedizin und Humangenetik   (Germany)

^d Institut für Humangenetik   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Praxis für Pränatale Diagnostik   (Germany)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h GATC Biotech AG   (Germany)

ⁱ LifeCodexx AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; AMNIOCENTESIS; ANEUPLOIDY; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME ABERRATION; CHROMOSOME DISORDERS; DNA SEQUENCE; DOWN SYNDROME; FEMALE; GENETICS; GERMANY; HIGH THROUGHPUT SEQUENCING; HUMAN; KARYOTYPING; MALE; MIDDLE AGED; MOSAICISM; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TRISOMY; YOUNG ADULT;

ADULT; ALGORITHMS; AMNIOCENTESIS; ANEUPLOIDY; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; GERMANY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MOSAICISM; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SWITZERLAND; TRISOMY; YOUNG ADULT;

EID: 84895072217     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4278     Document Type: Article

References (42)

1. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13weeks. Prenat Diagn 2011;31:7-15.
2. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
3. Kagan KO, Etchegaray A, Zhou Y, et al. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009;34:14-8.
4. Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618-24.
5. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105:16266-71.
6. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458-63.
7. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
8. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11.
9. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
10. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
11. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
12. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors. Prenat Diagn 2012;32(13):1225-32.
13. Liang D, Lv W, Wang H, et al. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn 2013;33(5):409-15.
14. Norton ME, Brar H, Weiss J, et al. Non-invasive Chromosomal Evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-e8.
15. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206(4):322.e1-5.
16. Ashoor G, Syngelaki A, Wang E, et al. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol 2013;41(1):21-5.
17. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207(5):374.
18. Liao GJ, Chan KC, Jiang P, et al. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA. PLoS One 2012;7(5):e38154.
19. Stumm M, Entezami M, Trunk N, et al. Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms. Prenat Diagn 2012;32:569-77.
20. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;33:1233-41.
21. Nicolaides KH, Syngelaki A, Gil M, et al. Validation of targeted sequencing of single-nucleotide polymorphis ms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013;33(6):575-9.
22. Gil MM, Quezada MS, Bregant B, et al. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013;42(1):34-40.
23. Chen EZ, Chiu RW, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6:e21791.
24. Benjamini Y, Speed TP. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res 2012;40:e72.
25. Alkan C, Kidd JM, Marques-Bonet T, et al. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 2009;41:1061-7.
26. Lun FM, Jin YY, Sun H, et al. Noninvasive prenatal diagnosis of a case of Down syndrome due to Robertsonian translocation by massively parallel sequencing of maternal plasma DNA. Clin Chem 2011;57(6):917-9.
27. Ashoor G, Syngelaki A, Poon LC, et al. Fetal fraction in maternal plasma cell-free DNA at 11-13weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013;41(1):26-32.
28. Grömminger S, Said H, Haid S, et al. A quantitative assay to determine the fetal fraction of cell-free DNA samples derived from maternal blood. Med Gen 2013;25:169-70.
29. Lau TK, Chen F, Pan X, et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012;25:1370-4.
30. Benn P, Borell A, Chiu R, et al. ISPD position statement from the aneuploidy screening committee on behalf of the board of the international society for prenatal diagnosis. Prenat Diagn 2013;33(7):622-9.
31. American College of Obstetricians and Gynecologists. Noninvasive prenatal testing for fetal aneuploidy. Committee opinion No. 545 December 2012. Obstet Gynecol 2012;120(6):1532-4.
32. Deutsche Gesellschaft für Humangenetik e.V. Stellungnahme der Deutschen Gesellschaft für Humangenetik (GfH) zur Analyse fetaler DNA aus dem mütterlichen Blut. 2012. Available from: http://www.gfhev.de/de/leitlinien/LL_und_Stellungnahmen/2012_11_12_GfH_Stellungnahme_Analyse_fetale_DNA.pdf [accessed on 05 December 2012].
33. Benn P, Cuckle H, Pergament E. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly. Ultrasound Obstet Gynecol 2012;39:127-30.
34. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal L 331; 07/12/1998: P. 0001-0037. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1998:331:0001:0037:EN:PDF [accessed on 14 December 2012].
35. Boon EM, Faas BH. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies. Prenat Diagn 2013;33(6):563-8.
36. Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011;365:1847-8.
37. Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012;58:1148-51.
38. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92(2):167-76.
39. Chen S, Lau TK, Zhang C, et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn 2013;33(6):584-90.
40. Lo YM, Chan KC, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2:61ra91.
41. Kitzman JO, Snyder MW, Ventura M, et al. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012;4:137ra76.
42. Chen S, Ge H, Wang X, et al. Haplotype-assisted accurate non-invasive fetal whole genome recovery through maternal plasma sequencing. Genome Med 2013;5(2):18.